Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1975 Feb;181(2):203–206. doi: 10.1097/00000658-197502000-00014

Efficacy of intravenous clindamycin and methicillin in gram-positive soft tissue infections.

K C Chessick, L A Begley, L E Curtis, E F Hirsch, C W Kaiser, C A Burek, H S Soroff
PMCID: PMC1343754  PMID: 1111453

Abstract

In a comparative study on a general surgical service, intravenous clindamycin phosphate or methicillin was used to treat a variety of soft tissue infections due to gram-positive organisms, chiefly staphylococci. The infections were rated according to severity, responsible organisms, and site of the infection. Excellent or good clinical and bacteriologic responses were obtained with both clindamycin and methicillin as adjuncts to basic surgical therapy in these soft tissue infections. The adverse effects of each drug were detailed, and were comparable. Clindamycin phosphate is a satisfactory substitute for methicillin in soft tissue infections secondary to gram-positive organisms.

Full text

PDF
203

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barrett F. F., McGehee R. F., Jr, Finland M. Methicillin-resistant Staphylococcus aureus at Boston City Hospital. Bacteriologic and epidemiologic observations. N Engl J Med. 1968 Aug 29;279(9):441–448. doi: 10.1056/NEJM196808292790901. [DOI] [PubMed] [Google Scholar]
  2. Bartlett J. G., Sutter V. L., Finegold S. M. Treatment of anaerobic infections with lincomycin and clindamycin. N Engl J Med. 1972 Nov 16;287(20):1006–1010. doi: 10.1056/NEJM197211162872002. [DOI] [PubMed] [Google Scholar]
  3. Bauer A. W., Kirby W. M., Sherris J. C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966 Apr;45(4):493–496. [PubMed] [Google Scholar]
  4. Benner E. J., Adams A. P., Jr Unusual resistance of Staphylococcus aureus to lincomycin and 7-chlorolincomycin. Antimicrob Agents Chemother (Bethesda) 1969;9:100–103. [PubMed] [Google Scholar]
  5. Carlisle H. N., Saslaw S. Comparison of clindamycin, erythromycin, and methicillin in streptococcal infections in monkeys. Antimicrob Agents Chemother. 1972 Jun;1(6):460–465. doi: 10.1128/aac.1.6.460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Carlisle H. N., Saslaw S. Therapy of staphylococcal infections in monkeys. VI. Comparison of clindamycin, erythromycin, and methicillin. Appl Microbiol. 1971 Mar;21(3):440–446. doi: 10.1128/am.21.3.440-446.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. De Haan R. M., Schellenberg D., Vanden Bosch W. D., Maile M. H. Clindamycin palmitate in healthy men: general tolerance and effect on stools. Curr Ther Res Clin Exp. 1972 Feb;14(2):81–90. [PubMed] [Google Scholar]
  8. DeHaan R. M., Metzler C. M., Schellenberg D., Vandenbosch W. D. Pharmacokinetic studies of clindamycin phosphate. J Clin Pharmacol. 1973 May-Jun;13(5):190–209. doi: 10.1002/j.1552-4604.1973.tb00208.x. [DOI] [PubMed] [Google Scholar]
  9. Garrison D. W., DeHaan R. M., Lawson J. B. Comparison of in vitro antibacterial activities of 7-chloro-7-deoxylincomycin, lincomycin, and erythromycin. Antimicrob Agents Chemother (Bethesda) 1967;7:397–400. [PubMed] [Google Scholar]
  10. Geddes A. M., Bridgwater F. A., Williams D. N., Oon J., Grimshaw G. J. Clinical and bacteriological studies with clindamycin. Br Med J. 1970 Jun 20;2(5711):703–704. doi: 10.1136/bmj.2.5711.703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gilbert D. N., Sanford J. P. Methicillin: critical appraisal after a decade of experience. Med Clin North Am. 1970 Sep;54(5):1113–1125. [PubMed] [Google Scholar]
  12. Kauffman R. E., Shoeman D. W., Suk-Han-Wan, Azarnoff D. L. Absorption and excretion of clindamycin-2-phosphate in children after intramuscular injection. Clin Pharmacol Ther. 1972 Sep-Oct;13(5):704–709. doi: 10.1002/cpt1972135part1704. [DOI] [PubMed] [Google Scholar]
  13. Kerstein M. D. Intravenous clindamycin phosphate in staphylococcal infections. Curr Ther Res Clin Exp. 1972 Mar;14(3):107–112. [PubMed] [Google Scholar]
  14. Martin W. J., Gardner M., Washington J. A., 2nd In vitro antimicrobial susceptibility of anaerobic bacteria isolated from clinical specimens. Antimicrob Agents Chemother. 1972 Feb;1(2):148–158. doi: 10.1128/aac.1.2.148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. McGehee R. F., Jr, Smith C. B., Wilcox C., Finland M. Comparative studies of antibacterial activity in vitro and absorption and excretion of lincomycin and clinimycin. Am J Med Sci. 1968 Nov;256(5):279–292. doi: 10.1097/00000441-196811000-00002. [DOI] [PubMed] [Google Scholar]
  16. Panzer J. D., Brown D. C., Epstein W. L., Lipson R. L., Mahaffey H. W., Atkinson W. H. Clindamycin levels in various body tissues and fluids. J Clin Pharmacol New Drugs. 1972 Jul;12(7):259–262. doi: 10.1002/j.1552-4604.1972.tb00052.x. [DOI] [PubMed] [Google Scholar]
  17. Rountree P. M., Beard M. A. Hospital strains of Staphylococcus aureus, with particular reference to methicillin-resistant strains. Med J Aust. 1968 Dec 28;2(26):1163–1168. doi: 10.5694/j.1326-5377.1968.tb83502.x. [DOI] [PubMed] [Google Scholar]
  18. Schumer W., Nichols R. L., Miller B., Samet E. T., McDonald G. O. Clindamycin in the treatment of soft-tissue infections. Arch Surg. 1973 Apr;106(4):578–581. doi: 10.1001/archsurg.1973.01350160190033. [DOI] [PubMed] [Google Scholar]
  19. Stiver H. G., Ronald A. R. Clinical and laboratory experience with clindamycin. Antimicrob Agents Chemother (Bethesda) 1970;10:481–485. [PubMed] [Google Scholar]
  20. Wagnerová M., Vacek V. Antistaphylococcal activity of clindamycin. Chemotherapy. 1971;16(4):247–251. doi: 10.1159/000220733. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES